Cassava Sciences, Inc.
SAVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $109 | $135 | $170 | $246 |
| - Cash | $129 | $121 | $201 | $233 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$19 | $14 | -$31 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$89 | -$68 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$141 | -$104 | -$79 | -$32 |
| % Margin | – | – | – | – |
| Net Income | -$24 | -$97 | -$76 | -$32 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.52 | -2.32 | -1.8 | -0.81 |
| % Growth | 77.6% | -28.9% | -122.2% | – |
| Operating Cash Flow | -$117 | -$82 | -$78 | -$30 |
| Capital Expenditures | -$0 | -$0 | -$3 | -$22 |
| Free Cash Flow | -$117 | -$82 | -$80 | -$52 |